Untangling Wild-Type Transthyretin Amyloidosis

Heart failure (HF) affects >5 million people in the United States, approximately one-half of whom have normal systolic left ventricular function (heart failure with preserved ejection fraction [HFpEF]) [(1)][1]. HF incidence increases with age, and multiple comorbidities contribute to its